Koninklijke Philips (NYSE:PHG – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.
Separately, Jefferies Financial Group raised shares of Koninklijke Philips from an “underperform” rating to a “hold” rating in a research note on Tuesday, October 29th. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold”.
Check Out Our Latest Analysis on PHG
Koninklijke Philips Stock Up 0.4 %
Hedge Funds Weigh In On Koninklijke Philips
A number of large investors have recently bought and sold shares of PHG. Millennium Management LLC raised its stake in Koninklijke Philips by 822.0% in the second quarter. Millennium Management LLC now owns 1,120,521 shares of the technology company’s stock worth $28,237,000 after buying an additional 998,995 shares in the last quarter. Bank of Montreal Can lifted its stake in shares of Koninklijke Philips by 2,883.5% during the 3rd quarter. Bank of Montreal Can now owns 982,199 shares of the technology company’s stock worth $32,157,000 after purchasing an additional 949,278 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Koninklijke Philips by 27.3% during the second quarter. Dimensional Fund Advisors LP now owns 4,036,336 shares of the technology company’s stock valued at $101,718,000 after purchasing an additional 864,951 shares in the last quarter. IHT Wealth Management LLC bought a new position in Koninklijke Philips in the third quarter worth about $19,593,000. Finally, Jane Street Group LLC lifted its position in shares of Koninklijke Philips by 361.7% during the first quarter. Jane Street Group LLC now owns 629,136 shares of the technology company’s stock valued at $12,583,000 after buying an additional 492,881 shares during the last quarter. Hedge funds and other institutional investors own 13.67% of the company’s stock.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Articles
- Five stocks we like better than Koninklijke Philips
- Learn Technical Analysis Skills to Master the Stock Market
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- What is a buyback in stocks? A comprehensive guide for investors
- Top-Performing Non-Leveraged ETFs This Year
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.